Management of type 2 diabetes: A handbook for general practice

Lifestyle interventions for management of type 2 diabetes

Smoking cessation

Download chapter

Last revised: 17 Sep 2020

Grade: Strong recommendation; high certainty

All people who smoke should be offered brief advice to quit smoking

These recommendations are drawn from the most recent recommendations from organisations including the National Health and Medical Research Council (NHMRC), the Scottish Intercollegiate Guidelines Network (SIGN), Diabetes Canada, the American Diabetes Association (ADA) and other relevant sources. Refer to ‘Explanation and source of recommendations’ for explanations of the levels and grades of evidence.

Smoking is associated with an increased risk of type 2 diabetes in men and women,39 and smoking negatively affects glycaemic control (eg smokers with type 2 diabetes need larger doses of insulin to achieve control similar to that of those who do not smoke).40

People with diabetes who smoke also further increase their risk of CVD, peripheral vascular disease and neuropathy (and progression of neuropathy). Smoking also increases the risks associated with surgery.8

The importance of smoking cessation in those with, or at risk of, type 2 diabetes cannot be overstated.

In the absence of contraindications, smokers who have evidence of nicotine dependence should be offered pharmacotherapy, along with behavioural support, if they are motivated to stop smoking. The choice of pharmacotherapy is based on efficacy, clinical suitability and patient choice.8

Guidelines for smoking cessation and a pharmacotherapy treatment algorithm are available in the RACGP’s Supporting smoking cessation: A guide for health professionals.

 

Aboriginal and Torres Strait Islander point

The following organisations provide resources and strategies for smoking cessation for Aboriginal and Torres Strait Islander people:

Specific support for Aboriginal and Torres Strait Islander people is also provided by Quitline.

  1. National Institute for Clinical Excellence. Guidance for the use of patient-education models for diabetes. Technology appraisal guidance TA60. London: NICE, 2003.
  2. Nordmann AJ, Suter-Zimmermann K, Bucher HC, et al. Meta-analysis comparing Mediterranean to low-fat diets for modification of cardiovascular risk factors. Am J Med 2011;124(9):841–51.e2.
  3. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2019;42:S1–194.
  4. Hordern MD, Dunstan DW, Prins JB, Baker MK, Singh MA, Coombes JS. Exercise prescription for patients with type 2 diabetes and pre-diabetes: A position statement from Exercise and Sport Science Australia. J Sci Med Sport 2012;15(1):25–31.
  5. National Health and Medical Research Council. Australian dietary guidelines. Canberra: NHMRC, 2013.
  6. Diabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2018;42:S1–325.
  7. Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: A joint statement by international diabetes organizations. Diabetes Care 2016;39(6):861–77.
  8. The Royal Australian College of General Practitioners. Supporting smoking cessation: A guide for health professionals. 2nd edn. East Melbourne, Vic: RACGP, 2019.
  9. Scottish Intercollegiate Guidelines Network. Management of diabetes: A national clinical guideline (updated 2017). Edinburgh: SIGN, 2017.
  10. Colberg SR, Sigal RJ, Yardley JE, et al. Physical activity/exercise and diabetes: A position statement of the American Diabetes Association. Diabetes Care 2016;39(11):2065–79.
  11. Tanaka H, Monahan KD, Seals DR. Age-predicted maximal heart rate revisited. J Am Coll Cardiol 2001;37:153–46.
  12. Gellish RL, Goslin BR, Olson RE, McDonald A, Russi GD, Moudgil VK. Longitudinal modeling of the relationship between age and maximal heart rate. Med Sci Sports Exerc 2007;39(5):822–29.
  13. Yang Z, Scott CA, Mao C, Tang J, Farmer AJ. Resistance exercise versus aerobic exercise for type 2 diabetes: A systematic review and meta-analysis. Sports Med 2014;44(4):487–99.
  14. Church T, Blair S, Cocreham S, et al. Effects of aerobic and resistance training on hemoglobin a1c levels in patients with type 2 diabetes: A randomized controlled trial. JAMA 2010;304(20):2253–62.
  15. Dijk J, Manders R, Tummers K, et al. Both resistance- and endurance-type exercise reduce the prevalence of hyperglycaemia in individuals with impaired glucose tolerance and in insulin-treated and non-insulin-treated type 2 diabetic patients. Diabetologia 2012;55(5):1273–82.
  16. Briffa T, Maiorana A, Sheerin NJ. Physical activity for people with cardiovascular disease: Recommendations of the National Heart Foundation of Australia. Med J Aust 2006;184(2):71–75.
  17. Royal Australian College of General Practitioners. Exercise: Type 2 diabetes. In: Handbook of non-drug interventions (HANDI). East Melbourne, Vic: RACGP, 2014.
  18. Zaharieva D, Riddell M. Prevention of exercise-associated dysglycaemia: A case study-based approach. Diabetes Spectr 2015;28:55–62.
  19. Shukla AP, Iliescu RG, Thomas CE, Aronne LJ. Food order has a significant impact on postprandial glucose and insulin levels. Diabetes Care 2015;38(7):e98–99.
  20. Evert AB, Boucher JL, Cypress M, et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 2014;37(Suppl 1):S120–43.
  21. Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: Review with meta-analysis of clinical studies. J Am Coll Nutr 2003;22:331–39.
  22. Bazzano LA, Serdula M, Liu S. Prevention of type 2 diabetes by diet and lifestyle modification. J Am Coll Nutr 2005;24:310–19.
  23. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346(6):393–403.
  24. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344(18):1343–50.
  25. Diabetes Prevention Program Research Group; Knowler W, Fowler S, Hamman R, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009;374(9702):1677–86.
  26. Look AHEAD Research Group; Wing RR, Bolin P, Brancati FL, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013;369(2):145–54.
  27. Shaw K, Gennat H, O’Rourke P, Del Mar C. Exercise for overweight or obesity. Cochrane Database of Systematic Reviews 2006;(4):CD003817. doi: 10.1002/14651858.CD003817.pub3.
  28. Thomas D, Elliott EJ, Naughton GA. Exercise for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2006;(3): CD002968. doi: 10.1002/14651858.CD002968.pub2.
  29. Malone M. Medications associated with weight gain. Ann Pharmacother 2005;39:2046–55.
  30. Rush E, Plank L, Chandu V, et al. Body size, body composition, and fat distribution: A comparison of young New Zealand men of European, Pacific Island, and Asian Indian ethnicities. N Z Med J 2004;117(1207):U1203.
  31. Royal Australian College of General Practitioners. Guidelines for preventive activities in general practice. 9th edn. East Melbourne, Vic: RACGP, 2016.
  32. National Heart Lung and Blood Institute. The practical guide: Identification, evaluation and treatment of overweight and obesity in adults. Bethesda, MD: National Institutes of Health, 2000.
  33. Australian Obesity Management Algorithm working group. Australian Obesity Management Algorithm. Australia and New Zealand: Australian Diabetes Society, Australian and New Zealand Obesity Society, Obesity Surgery Society of Australian and New Zealand, 2016.
  34. National Health and Medical Research Council. Clinical practice guidelines for the management of overweight and obesity in adults, adolescents and children in Australia. Melbourne: NHMRC, 2013.
  35. Lean MEJ, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): An open-label, cluster-randomised trial. Lancet 2018;391(10120):541–51.
  36. Khorgami Z, Shoar S, Saber AA, Howard CA, Danaei G, Sclabas GM. Outcomes of bariatric surgery versus medical management for type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. Obes Surg 2019;29(3):964–74.
  37. Colquitt JL, Pickett K, Loveman E, Frampton GK. Surgery for weight loss in adults. Cochrane Database System Rev 2014;(8):CD003641. doi: 10.1002/14651858.CD003641.pub4.
  38. Via M, Mechanick J. Nutritional and micronutrient care of bariatric surgery patients: Current evidence update. Curr Obes Rep 2017;6:286–96.
  39. US Department of Health and Human Services. How tobacco smoke causes disease: The biology and behavioral basis for smoking-attributable disease: A report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2010.
  40. Targher G, Alberiche M, Zenere MB, Bonadonna RC, Juggeo M, Bonara E. Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997;82(11):3619–24.
  41. Pietraszek A, Gregersen S, Hermansen K. Alcohol and type 2 diabetes: A review. Nutr Metab Cardiovasc Dis 2010;20:366–75.
  42. National Health and Medical Research Council. Australian guidelines to reduce health risks from alcohol [in publication]. Canberra: NHMRC, 2020.
  43. Cheyne EH, Sherwin RS, Lunt MJ, Cavan DA, Thomas PW, Kerr D. Influence of alcohol on cognitive performance during mild hypoglycaemia; implications for Type 1 diabetes. Diabet Med 2004;21(3):230–37.